Kuros Biosciences Gains FDA Clearance for Intervertebral Body Fusion Device

By Julie A. Vetalice

Kuros Biosciences received FDA clearance to market the Kuros Transforaminal Lumbar Interbody Fusion cage. The device is to be used with KUR-113, the company's Fibrin-PTH product candidate for spinal fusion. Clinical trials of the system will now commence.

The cage is available in a range of sizes and cleared for use in the lumbar spine in combination with autograft and/or allograft.

Source: Kuros Biosciences

Product Labels: Spinal Fusion

Tags: 510(k) Clearance, Regulatory